4-propionyloxy-4-phenyl-n-methylpiperidine has been researched along with Carcinoma, Non-Small Cell Lung in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Behnam-Motlagh, P; Brännström, T; Grankvist, K; Gudey, SK; Johansson, A; Karlsson, T; Tyler, A | 1 |
1 other study(ies) available for 4-propionyloxy-4-phenyl-n-methylpiperidine and Carcinoma, Non-Small Cell Lung
| Article | Year |
|---|---|
Targeting glucosylceramide synthase induction of cell surface globotriaosylceramide (Gb3) in acquired cisplatin-resistance of lung cancer and malignant pleural mesothelioma cells.
Topics: Apoptosis; ATP Binding Cassette Transporter, Subfamily B; Blotting, Western; Carcinoma, Non-Small-Cell Lung; Cell Membrane; Cell Proliferation; Ceramides; Cyclosporine; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Flow Cytometry; Glucosyltransferases; Humans; Immunosuppressive Agents; Lung Neoplasms; Meperidine; Mesothelioma; Mesothelioma, Malignant; Microscopy, Confocal; Multidrug Resistance-Associated Proteins; Trihexosylceramides; Tumor Cells, Cultured | 2015 |